Advanced Practice Midwife in San Angelo, TX Accepting Medicare

4 Advanced Practice Midwife nurses found. Showing 1 - 4

Kelsey Danielle Walts, Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3501 Knickerbocker Rd, San Angelo, TX 76904 Phone: 325-747-3408    Fax: 325-747-2525

Cynthia Stokes, RN, MSN, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1610 S Chadbourne St, San Angelo, TX 76903 Phone: 325-658-5339    Fax: 325-659-8534

Christina Arp, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 220 E. Harris, San Angelo, TX 76903 Phone: 325-481-2285    Fax: 325-481-2056

Opal L Smith, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 220 E. Harris, San Angelo, TX 76903 Phone: 325-658-1511

News Archive

Data from Seattle Genetics' brentuximab vedotin, SGN-75 programs to be presented at ASCO 2011

Seattle Genetics, Inc. today announced that data from its brentuximab vedotin and SGN-75 programs will be reported at the upcoming American Society of Clinical Oncology 2011 Annual Meeting being held June 3-7, 2011 in Chicago, IL.

New evidence that SARS-CoV-2 virus can infect the inner ear

Many Covid-19 patients have reported symptoms affecting the ears, including hearing loss and tinnitus. Dizziness and balance problems can also occur, suggesting that the SARS-CoV-2 virus may be able to infect the inner ear.

UNEP should work to bring about safe alternatives to DDT for malaria vector control

Some countries in Africa "still rely on dichlorodiphenyltrichloroethane (DDT) for malaria vector control," therefore "[i]t is ... problematic that the U.N. Environment Programme (UNEP), without the consent of member states, and violating its own treaties, exerts relentless pressure to ban DDT globally," Richard Tren, director of Africa Fighting Malaria, and Richard Nchabi Kamwi, Nambia's minister of health and social services, write in a BMJ opinion piece.

FDA allows IND application for ImmunoCellular's ICT-140 to treat ovarian cancer

ImmunoCellular Therapeutics, Ltd. announced that the US Food and Drug Administration (FDA) has allowed the investigational new drug (IND) application for ICT-140, paving the way for conducting a clinical trial.

Read more Medical News

› Verified 2 days ago